Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Pacific Biosciences of California Inc’s stock clocked out at $1.54, down -6.10% from its previous closing price of $1.64. In other words, the price has decreased by -$6.10 from its previous closing price. On the day, 8.01 million shares were traded. PACB stock price reached its highest trading level at $1.64 during the session, while it also had its lowest trading level at $1.51.
Ratios:
To gain a deeper understanding of PACB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.87 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 7.63 whereas as Long-Term Debt/Eq ratio is at 7.60.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 19 ’25 when Farmer Michele sold 5,195 shares for $1.00 per share. The transaction valued at 5,200 led to the insider holds 269,259 shares of the business.
HENRY CHRISTIAN O sold 12,497 shares of PACB for $17,583 on Mar 03 ’25. The insiders now owns 2,225,357 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Van Oene Mark, who serves as the insider of the company, sold 6,486 shares for $1.41 each. As a result, the insider received 9,126 and left with 1,497,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 462130880 and an Enterprise Value of 821131392. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.03 while its Price-to-Book (P/B) ratio in mrq is 5.04. Its current Enterprise Value per Revenue stands at 5.39 whereas that against EBITDA is -3.432.
Stock Price History:
The Beta on a monthly basis for PACB is 2.20, which has changed by -0.25242716 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 20.88%, while the 200-Day Moving Average is calculated to be -0.16%.
Shares Statistics:
It appears that PACB traded 9.16M shares on average per day over the past three months and 8906680 shares per day over the past ten days. A total of 300.04M shares are outstanding, with a floating share count of 264.16M. Insiders hold about 11.97% of the company’s shares, while institutions hold 62.90% stake in the company. Shares short for PACB as of 1752537600 were 44383358 with a Short Ratio of 4.84, compared to 1749772800 on 39640882. Therefore, it implies a Short% of Shares Outstanding of 44383358 and a Short% of Float of 16.830000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
